Insider · CIK 0001221451
ROCAMBOLI STEPHEN
Reports to the SEC for 5 companies · ANN ARBOR, MI
Transactions
34
Companies
5
Filings
13
CIK
0001221451
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-05-29 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-05-29 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2024-07-03 | TFF Pharmaceuticals, Inc.A Award | — |
| 2024-07-03 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award | — |
| 2024-05-23 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-05-23 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2024-04-18 | TFF Pharmaceuticals, Inc.Restricted stock unitsA Award | — |
| 2023-12-01 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award | — |
| 2023-08-15 | TFF Pharmaceuticals, Inc.P Purchase | +$5,000 |
| 2023-06-15 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-15 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2023-05-10 | ESPREsperion Therapeutics, Inc.P Purchase | +$12.1K |
| 2023-03-10 | TFF Pharmaceuticals, Inc.P Purchase | +$10.4K |
| 2022-12-29 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award | — |
| 2022-05-26 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-05-26 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-05-16 | TFF Pharmaceuticals, Inc.P Purchase | +$13.6K |
| 2021-03-15 | TFF Pharmaceuticals, Inc.M Exercise/Conversion | +$26.3K |
| 2021-03-15 | TFF Pharmaceuticals, Inc.M Exercise/Conversion | +$36.9K |
| 2021-03-15 | TFF Pharmaceuticals, Inc.S Sale | −$337K |
| 2021-03-15 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion | — |
| 2021-03-15 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion | — |
| 2020-11-11 | TFF Pharmaceuticals, Inc.M Exercise/Conversion | +$39.3K |
| 2020-11-11 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion | — |
| 2020-11-11 | TFF Pharmaceuticals, Inc.S Sale | −$248K |
| 2020-11-10 | TFF Pharmaceuticals, Inc.M Exercise/Conversion | +$53.2K |
| 2020-11-10 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)M Exercise/Conversion | — |
| 2020-11-10 | TFF Pharmaceuticals, Inc.S Sale | −$322K |
| 2020-08-24 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award | — |
| 2019-11-29 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award | — |
| 2019-10-29 | TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award | — |
| 2007-05-24 | VELCERA, INC.Options to purchase common stockA Award | — |
| 2006-06-29 | CytRx Oncology CorpCommon Stock Warrants (Right to Buy)J Other | — |
| 2003-10-28 | VioQuest Pharmaceuticals, Inc.Stock OptionA Award | — |
Recent filings
- 4ROCAMBOLI STEPHEN0001628280-25-028826SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-24-059872SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001628280-24-025213SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-24-035078SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-23-092820SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-23-067445SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001628280-23-022452SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001628280-23-017558SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-23-019577SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-22-084091SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001628280-22-015582SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-22-027789SEC(opens sec.gov)
- 4ROCAMBOLI STEPHEN0001213900-21-016184SEC(opens sec.gov)
Companies
Address
C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI, 48187